Consolidated Balance Sheet (unaudited) (USD $)	Mar. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 5,778,036	$ 3,196,831
Short term investments	5,000,000	5,000,000
Accounts receivable, net	1,847,372	3,236,917
Income tax receivable	244,720	244,720
Deferred tax asset	1,049,388	1,309,801
Prepaid expenses and other current assets	167,330	98,234
Total current assets	14,086,846	13,086,503
Deferred royalty buy-down	2,750,000	1,250,000
Deferred tax assets - long term	1,738,154	1,738,154
Patent costs, net	177,471	190,416
Total assets	18,752,471	16,265,073
Current liabilities:
Accounts payable and accrued expenses	2,281,176	601,002
Accrued tax liability	153,060	0
Deferred revenue	345,107	437,099
Accrued liabilities of discontinued operations	78,138	78,138
Total current liabilities	2,857,481	1,116,239
Long-term deferred revenue	259,238	276,520
Stockholders' equity:
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding	0	0
Common stock, $.001 par value; 10,000,000 shares authorized ; 6,554,743 and 6,530,743 shares issued at March 31, 2012 and December 31, 2011, respectively	6,555	6,531
Additional paid-in capital	20,269,082	20,049,196
Accumulated deficit	(2,549,515)	(3,291,904)
Treasury stock, 206,851 and 194,604 shares at cost at March 31, 2012 and December 31, 2011, respectively	(2,090,370)	(1,891,509)
Total stockholders' equity	15,635,752	14,872,314
Total liabilities and stockholders' equity	$ 18,752,471	$ 16,265,073